MY140404A - Catheter composition and uses thereof - Google Patents

Catheter composition and uses thereof

Info

Publication number
MY140404A
MY140404A MYPI20024411A MYPI20024411A MY140404A MY 140404 A MY140404 A MY 140404A MY PI20024411 A MYPI20024411 A MY PI20024411A MY PI20024411 A MYPI20024411 A MY PI20024411A MY 140404 A MY140404 A MY 140404A
Authority
MY
Malaysia
Prior art keywords
composition
effective amount
catheter composition
catheter
fibrin
Prior art date
Application number
MYPI20024411A
Other languages
English (en)
Inventor
Charles P Semba
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MY140404A publication Critical patent/MY140404A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI20024411A 2001-11-26 2002-11-26 Catheter composition and uses thereof MY140404A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33336901P 2001-11-26 2001-11-26

Publications (1)

Publication Number Publication Date
MY140404A true MY140404A (en) 2009-12-31

Family

ID=23302492

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20024411A MY140404A (en) 2001-11-26 2002-11-26 Catheter composition and uses thereof

Country Status (28)

Country Link
US (3) US20030206906A1 (enExample)
EP (1) EP1455858A4 (enExample)
JP (1) JP4458240B2 (enExample)
KR (2) KR20100102745A (enExample)
CN (1) CN100478027C (enExample)
AR (1) AR037437A1 (enExample)
AU (2) AU2002365408B2 (enExample)
BR (1) BR0215098A (enExample)
CA (1) CA2467645C (enExample)
CO (1) CO5580795A2 (enExample)
EA (1) EA007594B1 (enExample)
EC (2) ECSDI045123S (enExample)
HR (1) HRP20040502A2 (enExample)
HU (1) HUP0600436A3 (enExample)
IL (2) IL162083A0 (enExample)
IS (1) IS7275A (enExample)
ME (1) ME00015B (enExample)
MX (1) MXPA04004948A (enExample)
MY (1) MY140404A (enExample)
NO (1) NO331700B1 (enExample)
NZ (1) NZ533029A (enExample)
PL (1) PL371760A1 (enExample)
RS (1) RS46204A (enExample)
TW (1) TWI262794B (enExample)
UA (1) UA81235C2 (enExample)
UY (1) UY27550A1 (enExample)
WO (1) WO2003045466A2 (enExample)
ZA (1) ZA200404024B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030206906A1 (en) * 2001-11-26 2003-11-06 Genentech, Inc. Catheter composition and uses thereof
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
JP5566106B2 (ja) * 2006-08-28 2014-08-06 オムニオ・ヒーラー・アクチボラゲット 歯周病の阻止および治療、歯周創傷の治癒の改善および口腔衛生の促進を目的とする新規薬物
AU2007290881B2 (en) * 2006-08-28 2013-03-07 Omnio Healer Ab Candidates against infection
WO2008070353A2 (en) * 2006-11-07 2008-06-12 Genentech, Inc. Tissue plasminogen activator variant uses
RU2323001C1 (ru) * 2007-05-30 2008-04-27 Общество с ограниченной ответственностью "Научно-производственное предприятие "Техноген" Фармацевтическая композиция, обладающая фибринолитическим действием
JP5642540B2 (ja) 2007-06-01 2014-12-17 アロウ・インターナショナル・インコーポレイテッドＡｒｒｏｗ Ｉｎｔｅｒｎａｔｉｏｎａｌ， Ｉｎｃ． 組み合わされた線維素溶解性および抗菌性のカテーテル、およびその使用
JP2010538092A (ja) * 2007-09-07 2010-12-09 ユナイテッド セラピューティクス コーポレーション グラム陰性菌に対して選択的殺菌活性を有するバッファー溶液およびそれを使用する方法
US8545459B2 (en) * 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
EP2464406B1 (en) * 2009-08-10 2016-10-26 Proviflo, LLC Catheter lock solutions utilizing tocopherol and mid-chain fatty acids
CN103083726A (zh) * 2013-03-04 2013-05-08 昆明市第一人民医院 一种肝脏组织脱细胞液
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI831484L (fi) 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
US5000185A (en) 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5270198A (en) 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8820945D0 (en) * 1988-09-07 1988-10-05 Smith & Nephew Medical articles
FR2661790B1 (fr) * 1990-05-03 1995-08-25 France Etat Dispositif d'amplification tres large bande continu-hyperfrequences, notamment realisable en circuit integre.
WO1991017724A1 (en) 1990-05-17 1991-11-28 Harbor Medical Devices, Inc. Medical device polymer
US5399158A (en) 1990-05-31 1995-03-21 The United States Of America As Represented By The Secretary Of The Army Method of lysing thrombi
US5363754A (en) * 1991-09-03 1994-11-15 Grainco Queensland Co-Operative Association Limited Apparatus for preparing animal feedstuff from cotton seed
JPH05291891A (ja) * 1992-02-14 1993-11-05 Ricoh Co Ltd 一次乱数パルス列発生回路装置
NZ253556A (en) * 1992-06-03 1995-11-27 Genentech Inc Tissue plasminogen activator (t-pa) variants (with extended circulatory half-life and/or potency); preparation, compositions, host cells, dna sequences, and expression vehicles thereof
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US5362754A (en) * 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
US5849736A (en) 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
EP0730590B1 (en) 1993-11-24 2001-01-17 Dupont Pharmaceuticals Company isoxazoline and isoxazole fibrinogen receptor antagonists
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5509896A (en) 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
AU716005B2 (en) * 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
AU5526098A (en) 1996-12-23 1998-07-17 Biochem Pharma Inc. Bicyclic thrombin inhibitors
US5981826A (en) * 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
JPH10328293A (ja) 1997-06-04 1998-12-15 Unitika Ltd 医療用具及びその製造方法
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6174537B1 (en) * 1998-09-25 2001-01-16 Becton, Dickinson And Company Catheter flush solution and method for its use
BR0010381A (pt) 1999-03-11 2002-02-05 Du Pont Pharm Co Método de tratamento da trombose em um mamìfero, e uso de uma combinação de (i) um inibidor do fator xa, e (ii) um composto selecionado do grupo que consiste em aspirina, tpa, um antagonista gpiib/iiia, heparina de baixo peso molecular e heparina
CA2364252A1 (en) 1999-03-11 2000-09-14 Bristol-Myers Squibb Pharma Company Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders
CA2302720C (en) 1999-03-29 2009-07-14 Ed Geistlich Sohne Ag Fur Chemische Industrie Anticoagulant/sterilizing compositions and methods
US6187768B1 (en) * 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
US6592564B2 (en) * 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6350251B1 (en) 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
US20010031981A1 (en) 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
DE60133893D1 (de) 2000-05-10 2008-06-19 Ash Access Technology Inc Kathetersperrlösung mit photo-oxidant
US6772640B1 (en) * 2000-10-10 2004-08-10 Mks Instruments, Inc. Multi-temperature heater for use with pressure transducers
US20050215978A1 (en) 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
US20030206906A1 (en) 2001-11-26 2003-11-06 Genentech, Inc. Catheter composition and uses thereof
US20070014779A1 (en) 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
DE60311958T2 (de) 2003-02-03 2007-11-08 Polaschegg, Hans-Dietrich, Dr. Zusammensetzung zur Prävention von Infektionen durch subkutane Prothesen
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
WO2008070353A2 (en) 2006-11-07 2008-06-12 Genentech, Inc. Tissue plasminogen activator variant uses

Also Published As

Publication number Publication date
WO2003045466A2 (en) 2003-06-05
KR20100102745A (ko) 2010-09-24
NZ533029A (en) 2006-05-26
AU2002365408A1 (en) 2003-06-10
BR0215098A (pt) 2004-12-14
HRP20040502A2 (en) 2004-12-31
CN1617738A (zh) 2005-05-18
CN100478027C (zh) 2009-04-15
NO331700B1 (no) 2012-02-27
AU2002365408B2 (en) 2008-04-24
CA2467645A1 (en) 2003-06-05
PL371760A1 (en) 2005-06-27
AR037437A1 (es) 2004-11-10
UA81235C2 (en) 2007-12-25
RS46204A (sr) 2006-10-27
JP2005510302A (ja) 2005-04-21
NO20042693L (no) 2004-08-25
IL162083A0 (en) 2005-11-20
EA007594B1 (ru) 2006-12-29
UY27550A1 (es) 2003-06-30
WO2003045466A3 (en) 2003-10-09
US20060246050A1 (en) 2006-11-02
ZA200404024B (en) 2005-07-27
AU2008203131A1 (en) 2008-08-07
HUP0600436A3 (en) 2010-12-28
CA2467645C (en) 2017-01-17
TWI262794B (en) 2006-10-01
IL162083A (en) 2012-12-31
MXPA04004948A (es) 2004-08-11
TW200303743A (en) 2003-09-16
MEP8008A (xx) 2010-02-10
IS7275A (is) 2004-05-21
JP4458240B2 (ja) 2010-04-28
ECSDI045123S (enExample) 2004-07-23
US20030206906A1 (en) 2003-11-06
EP1455858A4 (en) 2006-02-15
HUP0600436A2 (en) 2006-09-28
EP1455858A2 (en) 2004-09-15
US7829082B2 (en) 2010-11-09
EA200400712A1 (ru) 2005-06-30
CO5580795A2 (es) 2005-11-30
ME00015B (me) 2010-06-10
US20060257390A1 (en) 2006-11-16
ECSP045123A (es) 2004-07-23
KR20040054803A (ko) 2004-06-25

Similar Documents

Publication Publication Date Title
TWI262794B (en) Catheter composition and uses thereof
EP1278939B8 (en) Well treatment fluids comprising chelating agents
PL352986A1 (en) Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
AU2002225687A1 (en) Storage solution containing photosensitizer for inactivation of biological contaminants
EP1576963A3 (en) Use of botulinum toxin in the treatment of pain due to an infection
MXPA03001195A (es) Fluido de tratamiento de sondeo viscoelastico.
NZ330843A (en) The use of a chelating agent in a peroxygen bleach containing composition to improve disinfecting properties
AU3863300A (en) Articles comprising oxidising and hemolytic agents
GB0408969D0 (en) Absorbent article with fluid treatment agent
ATE409222T1 (de) Verfahren zur herstellung einer reversibel inaktiven, angesäuerten plasminzusammensetzung
MXPA03000612A (es) Metodos y procesos mejorados para desinfeccion con yodo.
ZA200108912B (en) Attenuated microorganisms for the treatment of infection.
AU2001272852A1 (en) Composition for the treatment of migraine
DE60216233D1 (en) Carbolinderivate
MXPA02012076A (es) Compuestos quimicos.
MXPA02012659A (es) Derivados de pirazindiona condensados.
MXPA03002911A (es) Compuestos quimicos.
IL144847A0 (en) Combinations for the treatment of diseases involving angiogenesis
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
MXPA02012713A (es) Combinacion de inhibidores de fructosabisfosfatasas y agentes antidiabeticos, util para el tratamiento de la diabetes.
AU1520701A (en) Segmented process for cleaning-in-place
AU1861588A (en) A method for the determination of the activity of serine proteases or serine protease inhibitors
CA2481593A1 (en) Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin
MXPA03006099A (es) Articulo absorbente con agente de tratamiento fluido.
PT1187612E (pt) Utilizacao do riluzole para o tratamento da esclerose multipla